RBC Europe’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $98.9M | Buy |
182,038
+27,380
| +18% | +$14.9M | 4.76% | 7 |
|
|
2022
Q1 | $91.3M | Buy |
154,658
+38,176
| +33% | +$22.5M | 3.72% | 10 |
|
|
2021
Q4 | $77.7M | Buy |
116,482
+55,359
| +91% | +$36.9M | 3.42% | 10 |
|
|
2021
Q3 | $34.9M | Buy |
61,123
+4,697
| +8% | +$2.68M | 1.43% | 13 |
|
|
2021
Q2 | $28.5M | Buy |
56,426
+6,809
| +14% | +$3.43M | 1.29% | 15 |
|
|
2021
Q1 | $22.6M | Buy |
49,617
+6,616
| +15% | +$3.02M | 1.22% | 16 |
|
|
2020
Q4 | $20M | Buy |
43,001
+11,759
| +38% | +$5.48M | 1.15% | 16 |
|
|
2020
Q3 | $13.8M | Buy |
31,242
+14,690
| +89% | +$6.49M | 0.92% | 21 |
|
|
2020
Q2 | $6M | Buy |
16,552
+2,281
| +16% | +$826K | 0.46% | 38 |
|
|
2020
Q1 | $4.05M | Buy |
14,271
+2,378
| +20% | +$674K | 0.4% | 42 |
|
|
2019
Q4 | $3.86M | Buy |
11,893
+900
| +8% | +$292K | 0.34% | 50 |
|
|
2019
Q3 | $3.2M | Buy |
10,993
+575
| +6% | +$167K | 0.32% | 55 |
|
|
2019
Q2 | $3.06M | Buy |
10,418
+994
| +11% | +$292K | 0.31% | 62 |
|
|
2019
Q1 | $2.58M | Buy |
9,424
+1,359
| +17% | +$372K | 0.28% | 66 |
|
|
2018
Q4 | $1.8M | Buy |
8,065
+880
| +12% | +$197K | 0.24% | 78 |
|
|
2018
Q3 | $1.75M | Buy |
7,185
+6,390
| +804% | +$1.56M | 0.19% | 86 |
|
|
2018
Q2 | $165K | Buy |
795
+280
| +54% | +$58K | 0.02% | 277 |
|
|
2018
Q1 | $106K | Hold |
515
| – | – | 0.01% | 333 |
|
|
2017
Q4 | $97.8K | Hold |
515
| – | – | 0.01% | 355 |
|
|
2017
Q3 | $97.4K | Buy |
+515
| New | +$97.4K | 0.01% | 361 |
|